Skip to main content
Earnings Labs
Standard BioTools Inc. logo

Standard BioTools Inc. (LAB)

NASDAQ·Healthcare·Medical - Specialties

$0.65

+1.86%

Mkt Cap $251.04M

Analyst Ratings

No recent rating data.

Price Target (1 analysts)

$3.25

Range $3.25 – $3.25

Implied Upside

+401.7%

Consensus $3.25 vs current $0.65